Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 63629-1973

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 63629-1973). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Image 01)

This appears to be a table showing mean plasma concentrations of Dextro and Levoamphetamine, with measurements in ngint. The table appears to have two columns, one for each type of amphetamine, and six rows showing the concentration in decreasing order from 30 to 10. The text below the table contains some garbled words, but they appear to relate to the names and properties of the two types of amphetamines.*

FDA Label Image

Label (Lbl636291973)

The text contains information about a medication called NILD in the form of extended-release capsules. It includes the ingredients, dosage, storage instructions, and a warning to keep the medication out of reach of children. The medication contains amphetamine sulfate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and dextroamphetamine saccharate. It should be stored in a tight, light-resistant container at a temperature of 20° to 25°C and dispensed with a child-resistant closure. The NDC number and the number of capsules (100) are also provided.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.